BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Seegene, Inc. Announce SeePrep(TM) and SeeCycler(TM) to Create Complete Molecular Diagnostic System


7/26/2010 9:05:30 AM

ROCKVILLE, MD and SEOUL, SOUTH KOREA--(Marketwire - July 26, 2010) - Seegene today announced SeePrep™ and SeeCycler™, new clinical instrumentation optimized for Seegene's multiplex real-time detection tests. SeePrep performs automated magnetic bead nucleic acid extraction, and SeeCycler is an automated detection system for processing samples in real-time. With the addition of these equipment Seegene is now able to provide a complete molecular diagnostic workflow optimized for its multiplex tests, including nucleic acid extraction, amplification, real-time PCR testing and data analysis. The complete system will be on display at the 2010 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth #1800.

"Seegene multiplex real-time PCR products are defining a new era of powerful assays that can rapidly and accurately diagnose a pathogenic infection and genetic mutation. These tests arm medical professionals with the information they need for better and more cost-effective patient care," said Jong-Yoon Chun, Chief Executive Officer of Seegene. "SeePrep and SeeCycler are the cutting edge in test sample prep and processing, and are a perfect complement to our multiplex testing format. Used together as a complete system, clinicians will benefit from a comprehensive system which simplifies and speeds up the entire test process."

Seegene is pioneering a new category of multiplex PCR technology that enables the simultaneous detection of viruses and bacteria in a single reaction. Seegene currently has a wide range of assay panels for multiple pathogen screening. The assays primarily target viral and bacterial infections and include panels for viral respiratory infections, sexually transmitted diseases, herpes, diarrhea, HPV, viral meningitis and sepsis.

SeePrep is an automated nucleic acid extraction machine utilizing magnetic bead technology. The hallmark of the instrument is the ability to utilize specimens that are very difficult to extract by any other instrument.

SeeCycler uses patented block dissipation technology for accurate and fast heating and cooling rates, required for better efficiency in DNA amplification, resulting in fast reaction time. It has a capacity of 96 wells and covers and with 6 channels, 5 different analyses can be detected in one sample.

About Seegene

Seegene, Inc. is the leading biotechnology company developing, manufacturing and marketing innovative molecular diagnostic products and services. It holds proprietary technologies of both PCR and Real-time PCR named ACP™, DPO™, and READ™, which sets a standard in high-throughput and simultaneous multi-pathogen detection called "multiplex PCR." The novel multiplex Real-time PCR technology, READ™, overcomes the limitations of conventional Real-time PCR, providing dramatic improvement in sensitivity and specificity. Seegene holds three novel Molecular diagnostic platforms: Seeplex® system adapting DPO™ Technology, Anyplex® and Magicplex® system which are Real-time PCR detection platform adapting DPO™ and READ™ Technology. Seegene's products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene's mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using innovative proprietary technologies.

For more information please visit www.seegene.com or call +301-762-9066.


Contacts:
Miyoun Lee, MSc
Seegene, Inc.
301-762-9066
or
Constantine Theodoropulos
Base Pair Communications
617-816-4637



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES